XML 20 R6.htm IDEA: XBRL DOCUMENT v3.4.0.3
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Millions
12 Months Ended
Apr. 02, 2016
Mar. 28, 2015
Mar. 29, 2014
Cash flows from operating activities      
Net income $ 837.7 $ 881.0 $ 661.5
Adjustments to reconcile net income to net cash provided by operating activities:      
Depreciation and amortization 183.2 138.4 79.7
Equity compensation expense 48.4 48.9 29.1
Deferred income taxes (1.9) 6.2 (29.9)
Non-cash litigation related costs 1.9 5.7 2.0
Amortization of deferred rent 2.6 5.1 6.3
Loss on disposal of fixed assets 2.8 1.9 3.8
Impairment and write-off of property and equipment 10.9 0.8 1.3
Amortization of deferred financing costs 0.9 0.7 0.7
Tax benefits on exercise of share options (21.1) (45.3) (54.7)
Foreign currency (gains) losses 4.8 (1.5) 0.1
Gain on acquisition of MK Korea (3.7) 0.0 0.0
Loss (income) earned on joint venture 1.0 (0.1) (0.4)
Change in assets and liabilities:      
Receivables, net 52.5 (83.3) (104.4)
Inventories (16.3) (112.4) (158.2)
Prepaid expenses and other current assets (5.3) (20.1) (5.2)
Other assets (0.4) (6.3) (4.3)
Accounts payable 14.2 (8.6) 53.7
Accrued expenses and other current liabilities 104.5 36.3 126.5
Other long-term liabilities 11.7 10.5 25.4
Net cash provided by operating activities 1,228.4 857.9 633.0
Cash flows from investing activities      
Capital expenditures (369.2) (356.2) (184.7)
Purchase of intangible assets (11.4) (29.2) (28.8)
Investment in joint venture (1.0) (3.0) 0.0
Equity method investments 0.0 0.0 (2.0)
Cash received, net of cash paid for acquired businesses 0.5 0.0 0.0
Net cash used in investing activities (381.1) (388.4) (215.5)
Cash flows from financing activities      
Repurchase of treasury shares (1,152.4) (495.3) (2.4)
Tax benefits on exercise of share options 21.1 45.3 54.7
Exercise of employee share options 12.7 15.3 19.0
Repayments of borrowings under revolving credit agreement (199.8) 0.0 (21.1)
Borrowings under revolving credit agreement 192.6 0.0 21.1
Payment of deferred financing costs (2.4) 0.0 (0.2)
Other financing activities (0.1) 0.0 0.0
Net cash (used in) provided by financing activities (1,128.3) (434.7) 71.1
Effect of exchange rate changes on cash and cash equivalents 4.1 (27.1) (4.7)
Net (decrease) increase in cash and cash equivalents (276.9) 7.7 483.9
Beginning of period 978.9 971.2 487.3
End of period 702.0 978.9 971.2
Supplemental disclosures of cash flow information      
Cash paid for interest 1.5 0.7 0.7
Cash paid for income taxes 273.0 373.3 280.7
Supplemental disclosure of noncash investing and financing activities      
Accrued capital expenditures $ 33.6 $ 32.9 $ 16.3